Taimei Tech Repurchases 50,000 H Shares, Treasury Stock Rises to 10.78 Million

Bulletin Express10-28

Zhejiang Taimei Medical Technology Co., Ltd. (Taimei Tech) disclosed that it bought back 50,000 H shares on 28 October 2026 via the Hong Kong Stock Exchange at prices between HKD 4.115 and HKD 4.300 per share, for a total consideration of HKD 0.21 million. The volume-weighted average repurchase price was HKD 4.2435 per share.

Following the transaction, the company’s treasury share balance increased from 10.73 million to 10.78 million shares. Issued shares outstanding (excluding treasury shares) fell 0.03 % to 189.81 million, while total issued share capital remained unchanged at 200.59 million shares.

The repurchase was executed under a mandate approved on 23 June 2026, which authorises the company to buy back up to 20.02 million shares. Cumulative repurchases under this mandate now stand at 10.36 million shares, equivalent to 5.18 % of the share count at the mandate date, leaving capacity for a further 9.66 million shares.

All shares bought back on 28 October 2026 are being held in treasury. In line with Hong Kong Stock Exchange rules, Taimei Tech is restricted from issuing new shares or disposing of treasury shares until 27 November 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment